The purpose of this study is to establish an electrocardiogram (ECG) data library to facilitate future studies on heart disease. Additionally, the study will be used to monitor changes in the patient's standard of care throughout the study period and gather patient perspectives on routine diagnostic procedures and disease monitoring and feedback on the design of heart failure trials.
Eligibility
Sex
ALL
Min age
45 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria:
1. Male or female participants aged 45 to 80 years (inclusive) at the date of signing the informed consent.
2. Diagnosed with heart failure.
3. Able and willing to provide informed consent to participate.
Exclusion Criteria:
1. Diagnostic test results positive for:
1. HIV-1 or HIV-2 infection
2. Hepatitis B or Hepatitis C infection
2. Mental incapacity, language barriers or unwillingness to comply with the requirements of the protocol, which may preclude adequate understanding or cooperation during the study as judged by the Investigator.
3. Any condition judged by the Investigator to pose an undue risk while participating in the trial
4. Diagnostic results which are inconsistent with heart failure with mildly reduced or preserved ejection fraction as judged by the Investigator.
Primary outcome measure(s)
To generate high quality ECG data to establish an ECG library for the development of an ECG tool to monitor disease progression. — 18 months After providing informed consent, participants will then undergo a series of clinical assessments, and the participants' ECGs will be used to contribute to establishing an ECG library for future heart disease research.
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.